Literature DB >> 19633072

Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine-deficient area.

Semra Ayturk1, Alptekin Gursoy, Altug Kut, Cuneyd Anil, Asli Nar, Neslihan Bascil Tutuncu.   

Abstract

OBJECTIVE: Metabolic syndrome (MetS) is a cluster of metabolic abnormalities with insulin resistance (IR) as a major component. It has been recently questioned whether MetS and its related components are associated with functional and morphological alterations of the thyroid gland. The aim of our study is to examine thyroid volume and nodule prevalence in a case-control study of patients with MetS in a mild-to-moderate iodine-deficient area.
DESIGN: Two hundred and seventy-eight patients with MetS were randomly matched for age, gender, and smoking habits with 261 subjects without MetS. Serum TSH, free tri-iodothyronine and thyroxine, and the level of IR, which was estimated by the homeostasis model assessment for IR, as well as other MetS parameters were evaluated. Thyroid ultrasonography was performed in all subjects. All subjects with thyroid nodules >1 cm were offered to undergo thyroid fine needle aspiration biopsy.
RESULTS: TSH was significantly positively correlated with the presence of MetS diagnosis. There was no association between free thyroid hormone levels and MetS and its related components. Mean thyroid volume was significantly higher in patients with MetS than in controls (17.5 + or - 5.5 vs 12.2 + or - 4.2 ml, P<0.0001). Also the percentage of patients with thyroid nodules was significantly higher in patients with MetS (50.4 vs 14.6%, P<0.0001). Subjects were also divided into two groups according to the presence of IR. The group of subjects with IR had increased thyroid volume and nodule formation. The odds ratio for the development of thyroid nodule in the presence of IR was 3.2. TSH as well as all MetS components were found to be independent predictors for thyroid volume increase. IR but not TSH was found to be correlated with thyroid nodule formation. Thyroid cancer was diagnosed in 3 out of 38 patients with MetS who agreed to have a biopsy (7.9%). None of the subjects in the control group was diagnosed to have thyroid cancer.
CONCLUSIONS: The results suggest that patients with MetS have significantly increased thyroid volume and nodule prevalence. Multivariate regression analysis model demonstrated that the presence of IR contributed substantially to this increased risk. Our data provide the first evidence that IR is an independent risk factor for nodule formation in an iodine-deficient environment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19633072     DOI: 10.1530/EJE-09-0410

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  67 in total

1.  Association of primary aldosteronism with chronic thyroiditis.

Authors:  Chiara Sabbadin; Caterina Mian; Davide Nacamulli; Gabriella Donà; Fabio Presotto; Corrado Betterle; Marco Boscaro; Luciana Bordin; Decio Armanini
Journal:  Endocrine       Date:  2016-02-09       Impact factor: 3.633

2.  Morbid obesity in women is associated to a lower prevalence of thyroid nodules.

Authors:  Carlo Cappelli; Ilenia Pirola; Francesco Mittempergher; Elvira De Martino; Claudio Casella; Barbara Agosti; Riccardo Nascimbeni; Annamaria Formenti; Enrico Agabiti Rosei; Maurizio Castellano
Journal:  Obes Surg       Date:  2012-03       Impact factor: 4.129

3.  Relationship between metabolic syndrome and thyroid nodules and thyroid volume in an adult population.

Authors:  Wenxing Guo; Long Tan; Wen Chen; Lili Fan; Yanting Chen; Cong Du; Mei Zhu; Hongyan Wei; Wei Wang; Min Gao; Tingkai Cui; Jun Shen; Wanqi Zhang
Journal:  Endocrine       Date:  2019-03-27       Impact factor: 3.633

4.  Comment on "Metformin Decreases Thyroid Volume and Nodule Size in Subjects with Insulin Resistance: A Preliminary Study".

Authors:  Umit Cintosun; Mehmet Ilkin Naharci; Huseyin Doruk
Journal:  Med Princ Pract       Date:  2016-10-31       Impact factor: 1.927

5.  Relationship between metabolic syndrome and multinodular non-toxic goiter in an inpatient population from a geographic area with moderate iodine deficiency.

Authors:  D Rendina; G De Filippo; G Mossetti; G Zampa; R Muscariello; G Benvenuto; C L Vivona; S Ippolito; F Galante; G Lombardi; B Biondi; P Strazzullo
Journal:  J Endocrinol Invest       Date:  2011-07-05       Impact factor: 4.256

6.  Investigation of insulin resistance gene polymorphisms in patients with differentiated thyroid cancer.

Authors:  Mustafa Akker; Sibel Güldiken; Tammam Sipahi; Orkide Palabıyık; Ayhan Tosunoğlu; Özlem Çelik; Nermin Tunçbilek; Atakan Sezer; Necdet Süt
Journal:  Mol Biol Rep       Date:  2014-02-07       Impact factor: 2.316

7.  Thyroid Nodules in Type 2 Diabetes Mellitus.

Authors:  Hong-Mei Zhang; Qi-Wen Feng; Yi-Xin Niu; Qing Su; Xia Wang
Journal:  Curr Med Sci       Date:  2019-07-25

8.  Thyroid volume and its relation to anthropometric measures in a healthy cuban population.

Authors:  Silvia Turcios; Juan J Lence-Anta; Jose-Luis Santana; Celia M Pereda; Milagros Velasco; Mae Chappe; Idalmis Infante; Marlene Bustillo; Anabel García; Enora Clero; Stephane Maillard; Regla Rodriguez; Constance Xhaard; Yan Ren; Carole Rubino; Rosa M Ortiz; Florent de Vathaire
Journal:  Eur Thyroid J       Date:  2015-02-26

9.  Frequency of nodular goiter and autoimmune thyroid disease in patients with polycystic ovary syndrome.

Authors:  Cevdet Duran; Mustafa Basaran; Orkide Kutlu; Zehra Kucukaydin; Suleyman Bakdik; Ferda Sevimli Burnik; Uysaler Aslan; Sami Said Erdem; Samil Ecirli
Journal:  Endocrine       Date:  2014-12-19       Impact factor: 3.633

10.  Observations on factors that influence thyroid nodules in diabetic and non-diabetic patients in the Zhejiang province of China.

Authors:  Weiping Tu; Gengsheng Zhang; Shuifen Yu; Jimei Tang; Jiangsu Yu
Journal:  Int J Clin Exp Med       Date:  2015-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.